These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8561865)

  • 21. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.
    Normanno N; Bianco C; Damiano V; de Angelis E; Selvam MP; Grassi M; Magliulo G; Tortora G; Bianco AR; Mendelsohn J; Salomon DS; Ciardiello F
    Clin Cancer Res; 1996 Mar; 2(3):601-9. PubMed ID: 9816209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor alpha and mouse models of human breast cancer.
    Humphreys RC; Hennighausen L
    Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor-like growth factors. I. Breast malignancies and other epithelial proliferations in transgenic mice.
    Strayer DS; Yang S; Schwartz MS
    Lab Invest; 1993 Dec; 69(6):660-73. PubMed ID: 8264229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
    Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
    Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors.
    Stamp G; Fantl V; Poulsom R; Jamieson S; Smith R; Peters G; Dickson C
    Cell Growth Differ; 1992 Dec; 3(12):929-38. PubMed ID: 1335281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.
    Normanno N; De Luca A; Maiello MR; Bianco C; Mancino M; Strizzi L; Arra C; Ciardiello F; Agrawal S; Salomon DS
    Int J Oncol; 2004 Oct; 25(4):1013-20. PubMed ID: 15375551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of epidermal growth factor family gene members in early mouse development.
    Johnson SE; Rothstein JL; Knowles BB
    Dev Dyn; 1994 Nov; 201(3):216-26. PubMed ID: 7881126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
    Murakami A; Tanaka H; Matsuzawa A
    Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
    Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY
    Cancer Res; 2001 Feb; 61(3):984-90. PubMed ID: 11221894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
    Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
    Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
    Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
    Silvy M; Giusti C; Martin PM; Berthois Y
    Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.
    Bordoli MR; Stiehl DP; Borsig L; Kristiansen G; Hausladen S; Schraml P; Wenger RH; Camenisch G
    Oncogene; 2011 Feb; 30(5):548-60. PubMed ID: 20856199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.